240
Participants
Start Date
January 1, 2021
Primary Completion Date
December 30, 2025
Study Completion Date
December 30, 2025
Locoregional therapy
"TACE procedure The decision to utilize transarterial artery chemoembolization (TACE) was performed through the tumor-feeding artery. The embolization emulsion was a mixture of Epirubicin 30-60 mg, Lobaplatin 30-50 mg, and Lipiodol 10-30 ml, and it was infused into tumor-feeding arteries via a 2.7/2.8 Fr micro-catheter.~HAIC procedure Hepatic arterial infusion chemotherapy (HAIC) procedure was performed with FOLFOX regimen: 85 or 135 mg/m2 oxaliplatin from hour 0 to 2 on day 1400 mg/m2 leucovorin from hour 2 to 4 on day 1, and 400 mg/m2 fluorouracil bolus at hour 5 on the day 1; and 2400 mg/m2 fluorouracil over 46 h on days 1 and 2."
Bevacizumab
15mg/kg or 7.5mg/kg intravenously every 3 weeks
Atezolizumab
1200mg intravenously every 3 weeks
Tislelizumab
200mg intravenously every 3 weeks
Toripalimab
220mg intravenously every 3 weeks
Sintilimab
200mg intravenously every 3 weeks
Camrelizumab
200mg intravenously every 3 weeks
RECRUITING
Chinese PLA hospital, Beijing
Sun Yat-sen University
OTHER